ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

/PRNewswire/ — The largest real-world study of its kind, presented today atESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the…